Sandu Pharmaceuticals is currently trading at Rs. 65.85, up by 2.50 points or 3.95% from its previous closing of Rs. 63.35 on the BSE.
The scrip opened at Rs. 66.55 and has touched a high and low of Rs. 66.55 and Rs. 64.55 respectively. So far 1582 shares were traded on the counter.
The BSE group ‘X’ stock of face value Rs. 10 has touched a 52 week high of Rs. 86.00 on 26-Apr-2022 and a 52 week low of Rs. 43.35 on 21-Dec-2021.
Last one week high and low of the scrip stood at Rs. 67.50 and Rs. 62.50 respectively. The current market cap of the company is Rs. 55.82 crore.
The promoters holding in the company stood at 49.47%, while Institutions and Non-Institutions held 0.01% and 50.52% respectively.
Sandu Pharmaceuticals has entered into Memorandum of understanding (MoU) with Bach Ma Van Xuan Pharmaceuticals.
The purpose of this MOU is to further business relationship and to broaden the scope between two Companies in Vietnam and India. Specifically Bach Ma Van Xuan Company brings Sandu’s traditional medicine and cosmetic products to distribution in Vietnam.
Sandu Pharmaceuticals, popularly called by people Sandu Ayurveda, is one of the renewed brands when it’s come to Ayurvedic health care Products or Medicines.